Department of Paediatric Haematology and Oncology, Collegium Medicum, Nicolaus Copernicus University, ul. Curie-Skłodowskiej 9, 85-094 Bydgoszcz, Poland.
Qual Life Res. 2010 Mar;19(2):191-8. doi: 10.1007/s11136-009-9580-1.
Comparative assessment of the HRQL of paediatric survivors of brain tumours (BT) and of acute leukaemia against a population of their healthy peers.
The study consisted of patients who had completed treatment for BT (n=36) or acute leukaemia (n=35) and were aged between 8 and 19. Healthy children (n=60) were selected from among pupils of schools. HRQL was evaluated directly and indirectly on the basis of the Polish language version of the PedsQLTM 4.0 Generic Core scales. The influence of selected factors (sex, age, time from the end of treatment and type of treatment) on the HRQL result was analysed.
In all the aspects analysed (total, physical, psychosocial, emotional, social and school functioning), the HRQL of BT and leukaemia survivors was significantly lower in comparison to their healthy peers. The HRQL of patients after BT treatment was also significantly lower than that of the survivors of leukaemia. The parent-proxy reported HRQL was consistent with the children's selfassessment. Patients treated with radiotherapy presented a significantly lower evaluation of life quality in the physical sphere.
Evaluation of HRQL should be treated as an additional independent parameter in an assessment of the long-term results of oncological treatment.
对比评估脑瘤(BT)和急性白血病患儿幸存者的生活质量(HRQL)与健康同龄人的差异。
本研究纳入了已完成 BT(n=36)或急性白血病(n=35)治疗且年龄在 8 至 19 岁之间的患者。健康儿童(n=60)从学校的学生中选择。HRQL 直接和间接通过波兰语版 PedsQLTM 4.0 通用核心量表进行评估。分析了选定因素(性别、年龄、治疗结束时间和治疗类型)对 HRQL 结果的影响。
在分析的所有方面(总体、身体、心理社会、情感、社会和学校功能)中,BT 和白血病幸存者的 HRQL 明显低于健康同龄人。BT 治疗后患者的 HRQL 也明显低于白血病幸存者。父母代理报告的 HRQL 与儿童自我评估一致。接受放疗的患者在身体领域的生活质量评估明显较低。
HRQL 的评估应作为评估肿瘤治疗长期结果的附加独立参数。